Global Personal Use Glucometer Device Market Size - Share Outlook, Growth Analysis Report and Forecast Trends 2026-2030

The personal-use glucometer device market covers blood glucose monitoring tools designed for self-testing outside clinical settings, including traditional finger-prick meters, test strips, and increasingly popular continuous glucose monitoring systems. The broader blood glucose monitoring sector reached $16.46 billion in 2025 and is on track to grow to $25.41 billion by 2030 at a 9.1% CAGR, reflecting sustained demand across both developed and developing markets. While the overall monitoring market spans clinical and personal segments, the personal-use category, including self-monitoring devices, represents a significant and expanding share driven by consumer preference for home-based health management.

• •Market valued at $16.46 billion globally in 2025; projected to reach $25.41 billion by 2030
• •Compound annual growth rate of 9.1% over the forecast period
• •Self-monitoring blood glucose devices segment valued at $11.27 billion in 2024

The primary catalyst for market expansion is the global surge in diabetes cases, with the International Diabetes Federation estimating over 537 million adults living with the condition worldwide. An aging demographic profile in developed nations and rising obesity rates in emerging economies are compounding disease prevalence. Growing consumer health literacy, coupled with a shift toward preventive care and remote patient monitoring, is encouraging more individuals to adopt personal glucose monitoring devices for ongoing disease management.

• •Rising global diabetes prevalence driving demand for at-home blood glucose testing
• •Technological innovation in CGM and non-invasive monitoring devices boosting adoption rates
• •Increasing healthcare expenditures and insurance coverage for glucose monitoring in North America and Europe

The market is broadly segmented into self-monitoring blood glucose (SMBG) devices, including traditional glucometers and test strips, and continuous glucose monitoring (CGM) systems. SMBG remains the largest segment due to lower cost and widespread availability, though CGM is growing faster as reimbursement policies improve and consumer awareness rises. North America dominates with the highest revenue share, driven by advanced healthcare infrastructure and high diabetes prevalence, while Asia-Pacific is the fastest-growing region due to rising incidence rates and improving access to medical devices.

• •North America leads market share; U.S. segment projected to grow from $6.82 billion in 2023 to $12.94 billion by 2030 at 9.6% CAGR
• •Asia-Pacific emerging as the fastest-growing region, driven by increasing diabetes prevalence in China and India
• •Self-monitoring blood glucose devices expected to reach $33.30 billion by 2034 at a projected CAGR

What are the recent trends and outlook?

The convergence of glucose monitoring with digital health ecosystems, including smartphone apps, cloud data storage, and AI-driven insights, is a defining trend, enabling users and clinicians to make more informed treatment decisions. Miniaturization and non-invasive sensor technologies are attracting significant R&D investment, with the potential to disrupt traditional finger-prick methods. Over the forecast horizon, the market is expected to benefit from expanding indications for CGM in non-insulin-dependent Type 2 diabetes, further regulatory approvals, and growing retail access in developing markets.

• •Integration with digital health platforms and mobile applications driving next-generation product development
• •Emerging non-invasive glucose monitoring technologies expected to reshape market dynamics over the next decade
• •Projected market expansion to $25.41 billion by 2030, with CGM outpacing traditional SMBG growth